To further investigate the effects of MT1JP on tumor inhibition, we constructed a plasmid for overexpression of MT1JP in HepG2 and SMMC-7721 cells, which normally express MT1JP at lower levels than L02 cells. This evidence concerns the gene MT1JP and neoplasm.